Publication List English

2025/10/31
Zebrafish Xenograft Model for Predicting Cisplatin Efficacy in Muscle-Invasive Bladder Cancer

2025/10/16
AI-Driven Image Analysis for Precision Screening Transposon-Mediated Transgenesis of NFƒΘB eGFP Reporter System in Zebrafish

2025/08/06
Variation and classification of chemically-induced zebrafish malformations for the ICH S5 (R3) guideline: an atlas for zebrafish teratogenesis

2024/08/06
Validation of a new protocol for a zebrafish MEFL (malformation or embryo-fetal lethality) test method that conforms to the ICH S5 (R3) guideline

2024/05/21
In vivo assessment of individual and total proteinuria in zebrafish larvae using the solvatochromic compound ZMB741

tEstablishment of a drug evaluation model against light-induced retinal degeneration using adult pigmented zebrafish

                     
2016/06/06

Journal of Pharmacological Sciences
online 6 June 2016
doi:10.1016/j.jphs.2016.05.009

Yuichi Saitoa, Kazuhiro Tsuruma, Masamitsu Shimazawa, Yuhei Nishimura, Toshio Tanaka, Hideaki Hara

Abstract
Age-related macular degeneration (AMD) is a major cause of irreversible loss of central vision in the elderly. Zebrafish is an attractive animal model in some respects, lower cost, smaller housing facilities and easier genetic manipulation compared to rodents. The present study aimed to establish a drug evaluation method against light irradiation, as a dry AMD disease model, using adult pigmented zebrafish. Intravitreal administration of an antioxidant, N-acetylcysteine, protected against light-induced retinal degeneration in a concentration-dependent manner. We established a new drug evaluation model against light-induced retinal degeneration that can provide new knowledge about dry AMD pathology and therapy.

ŠΦ˜AƒŠƒ“ƒN

JPS

PubMed